Indications and uses
for gentle, reliable relief from occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
for gentle, reliable relief from occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
take as indicated by doctor this product must be given in a 6 to 8 oz. glass of milk or fruit juice or infant's formula to prevent throat irritation. Dose may be taken as a single daily dose or in divided doses dosage should be adjusted to individual response higher doses are recommended for initial therapy the effect on stools is usually apparent 1 to 3 days after the first dose Adults and children over 12 years ...
Active Ingredient: Docusate sodium 10 mg (in each 1 mL)
Purpose: Stool Softener
Ask doctor before use if you have
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition
If pregnant or breast feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| Adults and children over 12 years | 50 to 200 mg (1 to 4 teaspoonful) |
| Children 6 to under 12 years | 50 to 100 mg (1 to 2 teaspoonful) |
| Children 3 to under 6 years | 25 to 50 mg(1/2 to 1 teaspoonful) |
| Children under 3 years of age | Ask a doctor |
citric acid, D&C red no. 33, flavor, methylparaben, Poloxamer, propylene glycol, propylparaben, purified water, sodium citrate.
Questions
888-974-5279
This product is not manufactured or distributed by Purdue Products LP, distributor of Colace® Liquid.
Manufactured by:
Silarx Pharmaceuticals, Inc.
1033 Stoneleigh Ave
Carmel, NY 10512
USA
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1245686 | docusate sodium 50 MG in 5 mL Oral Solution | PSN | 3 |
| 1245686 | docusate sodium 10 MG/ML Oral Solution | SCD | 3 |
| 1245686 | docusate sodium 10 MG per 1 ML Oral Solution | SY | 3 |
| 1245686 | docusate sodium 100 MG per 10 ML Oral Solution | SY | 3 |
| 1245686 | docusate sodium 150 MG per 15 ML Oral Solution | SY | 3 |
| 1245686 | DOSS Sodium 10 MG/ML Oral Solution | SY | 3 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Code 128 | 17856011602 | 17856-0116 box labela.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0116-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1134-f424-e053-dadaa90a57ce | Silace Liquid |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0116-2 | Silace | 25 mL in 1 CUP | LIQUID | 25 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0116 | SILACE (DOCUSATE SODIUM) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 1 package rows | 20161026_b70aabb5-8b56-40ee-b46e-7eca3bf0bbe4.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0116-2 | ML - Milliliter | 17856-0116 | 019eaacd-2690-4bcf-9763-a86ded5694e2 | 1 | 2016-11-08 |
| 54838-116-80 | ML - Milliliter | 54838-116 | 8ad43c4d-ee45-4427-bc78-e543e6686759 | 1 | 2012-07-24 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17856-0116 | 17856-0116-2 |
| 54838-116 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Docusate sodium | F05Q2T2JA0 | ACTIB |
| anhydrous citric acid | XF417D3PSL | IACT |
| D&C red no. 33 | 9DBA0SBB0L | IACT |
| methylparaben | A2I8C7HI9T | IACT |
| propylene glycol | 6DC9Q167V3 | IACT |
| propylparaben | Z8IX2SC1OH | IACT |
| sodium citrate | 1Q73Q2JULR | IACT |
| water | 059QF0KO0R | IACT |
| Poloxamer 407 | TUF2IVW3M2 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1a663219-308a-4d3a-acfa-bb5ef9dc3fff | b70aabb5-8b56-40ee-b46e-7eca3bf0bbe4 | 2016-10-26 | Warnings | 1a663219-308a-4d3a-acfa-bb5ef9dc3fff b70aabb5-8b56-40ee-b46e-7eca3bf0bbe4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.